Cotinine is the principal metabolite of nicotine, used as the primary biomarker for tobacco exposure in clinical, occupational and epidemiological studies. Simson Pharma's Cotinine reference standard supports analytical method development and validation for nicotine-biomarker testing in biological samples.

Simson Pharma Global Ltd. (UK) and Simson Pharma Global LLC (USA) supply high-quality Cotinine Reference Standards, pharmacopoeial reference materials, and its related impurities to pharmaceutical manufacturers, CROs, analytical laboratories, universities, and regulatory organizations worldwide. To service the Europe and America market efficiently, Simson Pharma Limited has set up Simson Pharma Global Ltd. in United Kingdom and Simson Pharma Global LLC in USA respectively.